News Releases
Aethlon Medical to Present at 12th International Conference on DialysisPRNewswire SAN DIEGO, Jan. 19 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTCBulletinBoard: AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis, will give a clinical presentation of the Aethlon Hemopurifier® at the 12th International Conference on Dialysis on January 22nd. The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care. The conference will be held at the Marriott New Orleans in New Orleans, Louisiana. Additional information, including the speaker agenda, can be accessed online at: http://www.renalresearch.com. (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b) About Aethlon Medical Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.
Contacts:
RedChip Companies, Inc.
Jon Cunningham
1-800-733-2447, Ext. 107
Jon@redchip.com
Jim Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Senior VP Finance
858.459.7800 x300
jfrakes@aethlonmedical.com
Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-bAP Archive: http://photoarchive.ap.org PRN Photo Desk, photodesk@prnewswire.com SOURCE: Aethlon Medical, Inc. Web site: http://www.aethlonmedical.com/ |
